CoChat
Sign Up
Cited by 170Diabetes Management and EducationDiabetes Management and ResearchAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors

Hermanns, N., Kulzer, B., Krichbaum, M., Kubiak, T., Haak, T.·2005·Diabetic Medicine
DOI 10.1111/j.1464-5491.2005.01414.x
Open this paper in CoChat — free account

Abstract

Aims The aims of this study were to examine (1) the prevalence of clinical and subclinical anxiety and affective disorders in a sample of diabetic patients attending a secondary care clinic in Germany and (2) risk factors associated with the occurrence of these disorders. Methods Four hundred and twenty diabetic patients (36.9% Type 1; 24.7% Type 2; 38.4% Type 2 with insulin) participated in a questionnaire‐based screening survey. Those who screened positive received a diagnostic interview. Results Prevalence of clinical affective disorders was 12.6%, with an additional 18.8% of patients reporting depressive symptoms without fulfilling all criteria for a clinical affective disorder. The prevalence of anxiety disorders was 5.9%, with an additional 19.3% of patients reporting some anxiety symptoms. The comorbidity rate of affective and anxiety disorders was 1.8%, whereas 21.4% of the diabetic patients reported elevated affective as well as anxiety symptomatology. Logistic regression established demographic variables such as age, female gender and living alone as well as diabetes‐specific parameters such as insulin treatment in Type 2 diabetes, hypoglycaemia problems and poor glycaemic control as risk factors for affective disorders. For anxiety symptoms female gender, younger age and Type 2 diabetes were significant independent variables. Conclusion The prevalence of affective disorders in diabetic patients was twofold higher than in the non‐diabetic population, whereas prevalence for anxiety disorders was not increased. Analysis of risk factors can facilitate the identification of patients who are at a greater risk for these disorders.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2005.01414.x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 5

  1. 10.1002/1520-6394(2000)12:1 <69::AID-DA9>3.0.CO;2-K · DOI
  2. World Health Organisation., 2003, International Classification of Diseases and Related Disorders (ICD‐10)
  3. Rubin RR, 2000, Diabetes and quality of life. Preface., Diabetes Spectrum, 13, 21
  4. Thefeld W, 1999, Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands, Gesundheitswesen, 2, S85
  5. Herpertz S, 2003, Evidenzbasierte Diabetes‐Leitlinie DDG. Psychosoziales und Diabetes mellitus, Diabetes Stoffwechsel, 12, 35

Cited by

Sorted by citations

See all 170

Related

Metadata

Authors
Hermanns, N., Kulzer, B., Krichbaum, M., Kubiak, T., & Haak, T.
Affiliations
  • German Diabetes Center Mergentheim (DE)
  • University of Bamberg (DE)
Corresponding author
Hermanns, N.
ORCID
Venue
Diabetic Medicine
Publisher
Wiley
Published
2005-02-16
Volume
22
Issue
3
Pages
293-300
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
DOI
10.1111/j.1464-5491.2005.01414.x
OpenAlex
W2103920393
Cited by
170
References
39
Citations by year
2026: 4 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 8 · 2017: 13 · 2016: 11 · 2015: 13 · 2014: 6 · 2013: 10 · 2012: 17
FWCI
3.75
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
diabetes mellitus, mood disorders, anxiety disorders, depression, comorbidities, prevalence, risk factors, type 1 diabetes, type 2 diabetes, insulin therapy, hypoglycemia, glycemic control, subclinical symptoms
MeSH terms
Adolescent, Adult, Age Factors, Anxiety, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Risk Factors, Sex Factors, Comorbidity, Prevalence, Logistic Models, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review